Eurozone plans to formalize passenger data, improve security
The European Commission last week proposed rules governing the use of Advance Passenger Information in a bid to strengthen border security.
As commissioner for home affairs Ylva Johansson explained during a press conference, travel in and out of the – the 26 European countries between which passengers are free to travel without visas – involves the obligation to give border authorities Personal Name Records . That's just the minimal information passengers provide airlines when booking tickets.[PDF] – flight details and passenger passport data collected by airlines upon check-in. It's provided to border authorities as a passenger manifest list.
"With this proposal, we will make it mandatory to share the Advanced Passenger Information for all flights that go in and out of Schengen but also for intra-Schengen flights that are the same as those that are required for the PNR,"Johansson."This will significantly help to prepare the readiness for the border guards – what kind of people they will expect – but also of course to track significant criminal individuals.
According to Johansson, PNR sharing alone is insufficient to catch criminals because they often book multiple tickets on airlines at the same time to make it difficult for authorities to know where they're actually traveling. With the addition of obligatory, standardized API data, authorities should be better able to determine who is traveling where and when.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Putin’s Ploy To Lure In Fighters From Central Asia Is Falling Short | OilPrice.comRussian President Vladimir Putin’s ploy to lure in new fighters with the promise of Russian citizenship isn’t likely to work as well as he thinks it will
Read more »
Coal Is Fueling A Pollution Problem In Central Asia | OilPrice.com'In the flu season, we see that people's symptoms are worse. Their immunity is weakening. If coughs used to last two weeks, now we see that people have coughs that last for a month or six weeks' - Ermek Ismailov, a Bishkek-based physician
Read more »
Central banks should beware mistaking wage rises for an inflation problem\n\t\t\tLet our global subject matter experts broaden your perspective with timely insights and opinions you\n\t\t\tcan’t find anywhere else.\n\t\t
Read more »
Ecstatic scenes in Buenos Aires as Argentina soars to World Cup victoryA sea of blue-and-white fans crowded into central Buenos Aires waving flags and blaring horns as Argentina soared to victory in the World Cup final.
Read more »
Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval - DrugsUse of the gabapentinoids for pain continues to increase. In 2018, the US Food and Drug Administration (FDA) strengthened the warnings for both gabapentin and pregabalin to emphasize the central nervous system side effects and the risk of respiratory depression, especially when combined with other centrally acting drugs. We reviewed the published comparative effectiveness literature for gabapentinoids for pain as well as all trials (published and unpublished) used by the FDA for the approval of the five pain indications for these agents (one for gabapentin, four for pregabalin). Among the findings of interest are the fact that the FDA rejected the application for gabapentin for diabetic peripheral neuropathy based on the risk versus benefit profile of that drug in the clinical trials that were submitted by the manufacturer. Additionally, both the comparative effectiveness trials as well as the studies used by the FDA tend to be short in duration and show only modest pain benefits for the gabapentinoids. The placebo response in these trials was frequently one-third to one-half as great as the pain benefit demonstrated by the gabapentinoid. Based on the available clinical trial evidence, we feel prescribers should be cautious when using gabapentinoids for pain, particularly when using these agents for a prolonged period or when combined with other, centrally acting agents.
Read more »
British Airways: Flights leaving US grounded over technical issueBritish Airways apologises to passengers left waiting in airports and on runways across the US.
Read more »